Kate Rogers our new CEO

Kate Rogers joins from her previous role at GSK plc as Global Finance Transformation Lead at GSK. She also continues to serves as Non-Executive Director and Audit Committee Chair for Ixico Plc, a Medical Imaging company for Biopharmaceutical clinical research.

Previous to leading the recent transformation, Kate was CFO for Laboratoire Glaxo SmithKline SaS (GSK France) and has held senior finance, business transformation and leadership roles in GSK over a period of 20 years.

Kate has a degree in Engineering Science from Oxford University and is a Chartered Management Accountant. After graduating from Oxford, Kate joined Unilever as a management trainee, where she developed her early career in commercial finance and change management. From Unilever, Kate joined the pharmaceutical and life sciences industry, and has a deep belief and passion for enabling scientific advances to improve human health.

Kate Rogers said “I am excited finally to join the FLF and am looking forward to making a difference in this disease, driving our ambitions and finding routes for transformative change in scientific research. I’ll be working tirelessly with the teams to progress the search for better treatments and secure a cure for FL patients, and I can’t wait to get started”

The FLF is dedicated to improving lives for the thousands living with FL today and for everyone who is diagnosed tomorrow.